Roles of antiestrogen binding sites in human endometrial cancer cells

ISSN:
0022-4731
Source:
Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
Topics:
Biology
Chemistry and Pharmacology
Type of Medium:
Electronic Resource
URL:
_version_ 1798291106962604032
autor Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
autorsonst Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
book_url http://linkinghub.elsevier.com/retrieve/pii/0022-4731(87)91043-0
datenlieferant nat_lic_papers
fussnote Estrogen-noncompatible antiestrogen binding sites (AEBS) as well as estrogen receptors (ER), and the growth-inhibitory effect of tamoxifen were investigated in two human endometrial cancer cell lines, IK-90 and HEC-IA cells. IK-90 cells contained specific AEBS, but no ER was found in these cells. Scatchard plot analysis of AEBS in 12,000 g supernatant from IK-90 cells showed a high affinity binding site for tamoxifen (K"d:5.6 +/- 1.0nM) with the maximum binding site of 457 +/- 47 fmol/mg protein. However, no measurable ER or AEBS was found in HEC-IA cells. The effect of tamoxifen on the growth of cells was found to be identical in both cell lines; the addition of 10 μ M tamoxifen to culture medium was cytocidal whereas tamoxifen at lower concentrations (1 nM-1μM) did not significantly affect the growth of both IK-90 and HEC-IA cells. These results demonstrate for the first time the presence of AEBS in human endometrial cancer cells. The present results also suggest that AEBS does not play a fundamental role in mediating the growth:inhibitory effect of tamoxifen in endometrial cancer cells.
hauptsatz hsatz_simple
identnr NLZ18636704X
issn 0022-4731
journal_name Journal of Steroid Biochemistry
materialart 1
package_name Elsevier
publikationsort Amsterdam
publisher Elsevier
reference 26 (1987), S. 705-711
search_space articles
shingle_author_1 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
shingle_author_2 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
shingle_author_3 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
shingle_author_4 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
shingle_catch_all_1 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
Roles of antiestrogen binding sites in human endometrial cancer cells
0022-4731
00224731
Elsevier
shingle_catch_all_2 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
Roles of antiestrogen binding sites in human endometrial cancer cells
0022-4731
00224731
Elsevier
shingle_catch_all_3 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
Roles of antiestrogen binding sites in human endometrial cancer cells
0022-4731
00224731
Elsevier
shingle_catch_all_4 Hayashida, M.
Terakawa, N.
Shimizu, I.
Ikegami, H.
Wakimoto, H.
Aono, T.
Tanizawa, O.
Matsumoto, K.
Roles of antiestrogen binding sites in human endometrial cancer cells
0022-4731
00224731
Elsevier
shingle_title_1 Roles of antiestrogen binding sites in human endometrial cancer cells
shingle_title_2 Roles of antiestrogen binding sites in human endometrial cancer cells
shingle_title_3 Roles of antiestrogen binding sites in human endometrial cancer cells
shingle_title_4 Roles of antiestrogen binding sites in human endometrial cancer cells
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
timestamp 2024-05-06T08:27:21.447Z
titel Roles of antiestrogen binding sites in human endometrial cancer cells
titel_suche Roles of antiestrogen binding sites in human endometrial cancer cells
Estrogen-noncompatible antiestrogen binding sites (AEBS) as well as estrogen receptors (ER), and the growth-inhibitory effect of tamoxifen were investigated in two human endometrial cancer cell lines, IK-90 and HEC-IA cells. IK-90 cells contained specific AEBS, but no ER was found in these cells. Scatchard plot analysis of AEBS in 12,000 g supernatant from IK-90 cells showed a high affinity binding site for tamoxifen (K"d:5.6 +/- 1.0nM) with the maximum binding site of 457 +/- 47 fmol/mg protein. However, no measurable ER or AEBS was found in HEC-IA cells. The effect of tamoxifen on the growth of cells was found to be identical in both cell lines; the addition of 10 μ M tamoxifen to culture medium was cytocidal whereas tamoxifen at lower concentrations (1 nM-1μM) did not significantly affect the growth of both IK-90 and HEC-IA cells. These results demonstrate for the first time the presence of AEBS in human endometrial cancer cells. The present results also suggest that AEBS does not play a fundamental role in mediating the growth:inhibitory effect of tamoxifen in endometrial cancer cells.
topic W
V
uid nat_lic_papers_NLZ18636704X